Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

Chulalongkorn University15 enrolled

Overview

The purpose of this trial is to see if the 99mTechnetium-MIBI SPECT-CT can be a tool for preoperative evaluation of cervical node metastasis in papillary thyroid cancer.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Papillary Thyroid Cancer

Interventions

99mTc-MIBI SPECT-CTRADIATION

99mTc-MIBI SPECT-CT for abnormal cervical lymph node

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * papillary thyroid cancer Exclusion Criteria: * pregnancy * Bleeding abnormality * Prior history of head and neck cancer * can not perform 99mTechnetium-MIBI SPECT-CT * can not perform 131I remnant Ablation * Prior any head and neck surgery within 3 months * Prior deep neck infection within 3 months

Locations (1)

King Chulalongkorn Hospital

Pathumwan, Bangkok, Thailand

Outcomes

Primary Outcomes

Diagnostic Tool Statistic (PPV , NPV , Sensitivity , Specificity , Accuracy )

Time frame: 18 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.